Contact
Please use this form to send email to PR contact of this press release:
PERTHERA ANNOUNCES LANDMARK STUDY SHOWING MULTI-OMIC TESTING’S ROLE IN IMPROVING OUTCOMES FOR METASTATIC BREAST CANCER
TO:
Marketing Division
Perthera Inc
+1 703-286-0780